SHG · Healthcare

Jiangsu Hengrui Medicine Co Ltd (600276)

Drug Manufacturers - Specialty & Generic

Jiangsu Hengrui Medicine Co Ltd (600276) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 600276

P/E ratio

18.00

Jiangsu Hengrui Medicine Co Ltd (600276) — FAQ

What is 600276's P/E ratio?

The price-to-earnings (P/E) ratio for Jiangsu Hengrui Medicine Co Ltd (600276) is 18.00 (data as of 2026-05-24).

Does Jiangsu Hengrui Medicine Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Jiangsu Hengrui Medicine Co Ltd (600276). Check the MyAverix Finance app for the latest dividend data.

What sector is Jiangsu Hengrui Medicine Co Ltd in?

Jiangsu Hengrui Medicine Co Ltd (600276) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 600276 listed on?

600276 is listed on SHG.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)